Compound K (CK), another kind of ginsenoside, enhanced the susceptibility of 143B osteosarcoma cells to cisplatin through induction of apoptosis via mitochondria-mediated pathways such as cytochrome C release [70]. The gene discussed is CYCS; the disease is osteosarcoma.